Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × idelalisib × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Neoplasm Metastasis 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Docetaxel 8 pembrolizumab 7 Pemetrexed 5 Carboplatin 5 Erlotinib Hydrochloride 4 toripalimab 3 Radiosurgery 3 Oxaliplatin 3 Nivolumab 3 Gemcitabine 3 Etoposide 3 Cisplatin 3 Bevacizumab 3 rociletinib 2 lorlatinib 2 fludarabine 2 atezolizumab 2 Vinorelbine 2 Topotecan 2 Radiotherapy 2 Platinum 2 Paclitaxel 2 Itraconazole 2 Irinotecan 2 Interleukin-2 2 Cyclophosphamide 2 Cetuximab 2 vinflunine 1 vandetanib 1 talazoparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03257722 2024-02-28

PIL

Augusta University

Phase 1/2 Terminated

4 enrolled 5 charts

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡